Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:
Trade Name: Settle
Reference: A011453
Active Ingredient and Concentration:
Mycobacterium cell wall fraction 1mg/mL
Formulation Type: Aqueous suspension
General Use Claim:
An immunotherapeutic agent for use by or under the direction of a registered Veterinarian as an aid in the treatment of Equine Endomertitis caused by Streptococcus zooepidemicus.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
- must state in full the reasons for making the submission;
- may state any decision sought on that application; and
- must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
- where submissions on this application are to be sent;
- where requests for copies of the public information relating to the application can be sent;
- where public information relating to the application can be viewed; and
- the director-general’s address for service:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
NovaVive Inc, 79 Howard Crescent, Belleville, Ontario K8N 4Z7, Canada. Postal Address: PO Box 3005, RR#7, Belleville, Ontario K8N 4Z7, Canada.
Dated at Wellington this 30th day of May 2017.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).